Evaluation of the safety of a no-animal stabilized hyaluronic acid (NASHA - Q-Medical, Sweden) in European countries: A retrospective study from 1997 to 2001

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 4, 2004, Pages 422-425

  Andre P ^a  

^a NONE   (France)

Author keywords

Adverse reactions; Filler agents; Hyaluronic acid; NASHA

Indexed keywords

HYALURONIC ACID; BIOMATERIAL; DRUG DERIVATIVE; RESTYLANE;

ARTICLE; BACTERIAL INFECTION; DELAYED HYPERSENSITIVITY; ESTHETICS; EUROPE; HERPES LABIALIS; HYPERSENSITIVITY REACTION; INCIDENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SAFETY; SHORT SURVEY; SKIN ABSCESS; SKIN INFECTION; SKIN SENSITIVITY; SKIN TEST; SPECIES DIFFERENCE; CHEMICALLY INDUCED DISORDER; CUTANEOUS PARAMETERS; DRUG HYPERSENSITIVITY; ESTHETIC SURGERY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INFECTION; INFORMATION PROCESSING; INTRADERMAL DRUG ADMINISTRATION;

BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; DATA COLLECTION; DRUG HYPERSENSITIVITY; HUMANS; HYALURONIC ACID; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; INFECTION; INJECTIONS, INTRADERMAL; RETROSPECTIVE STUDIES; SKIN AGING;

EID: 3242758340     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00934.x     Document Type: Article

References (14)

1. Castrow FF II, Krull EA. Injectable collagen implant - update. J Am Acad Dermatol 1983; 9: 889-893.
2. Tromovitch TA, Stegman SJ, Glogau RG. Zyderm collagen: implantation technics. J Am Acad Dermatol 1984; 10: 273-278.
3. Hanke CW, Higley HR, Jolivette DM et al. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 1991; 25: 319-326.
4. André P. Facial lipoatrophy secondary to a new synthetic filler device (Profill) treated by lipofilling. J Cosm Dermatol 2002; 2: 59-61.
5. Piacquadio D, Jarcho M, Goltz R. Evaluation of hylan b gel as a soft tissue augmentation implant material. J Am Acad Dermatol 1997; 36: 544-549.
6. Duranti F, Salti G, Bovani B et al. Injectable hyaluronic acid gel for soft tissue augmentation: a clinical and histological study. Dermatol Surg 1998; 24: 1317-1325.
7. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994; 47: 536-566.
8. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 2000; 26: 135-137.
9. Friedman PM, Mafong EA, Kauvar AN, Geronemus R. Safety data of injectable non animal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002; 28: 491-495.
10. Lowe NJ, Maxwell CA, Lowe P et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001; 45: 930-933.
11. Kein AW. In favor of double testing. J Dermatol Surg Oncol 1989; 15: 263.
12. Micheels P. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg 2001; 27: 185-191.
13. Q-Med Sweden. Company report. Protein Content in Q-Medical Aesthetic Products (Restylane, Restylane Fine Lines, Perlane). Q-Medical, Uppsala, Sweden, 2001.
14. Chanz S, Schippert W, Ulmer A et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002; 146: 928-929.